Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Btk function in B cell development and response

A B Satterthwaite1, Z Li, O N Witte

  • 1Department of Microbiology and Molecular Genetics, University of California, Los Angeles 90095-1662, USA.

Seminars in Immunology
|August 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in PET Detection of the Antitumor T Cell Response.

Advances in immunology·2016
Same author

ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.

Leukemia·2010
Same author

Epithelial stem cells of the prostate and their role in cancer progression.

Cold Spring Harbor symposia on quantitative biology·2008
Same author

Prostate stem cells and prostate cancer.

Cold Spring Harbor symposia on quantitative biology·2006
Same author

Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.

Proceedings of the National Academy of Sciences of the United States of America·2004
Same author

Analysis of Bcr-Abl function using an in vitro embryonic stem cell differentiation system.

Methods in molecular biology (Clifton, N.J.)·2002
Same journal

Myeloid cells as sources and targets of IL-1 family cytokines in cancer.

Seminars in immunology·2026
Same journal

Interleukin-1-mediated inflammatory memory: Protective training or maladaptive tumor imprinting?

Seminars in immunology·2026
Same journal

Chronic stress at the crossroads: Decoding the HPA-SAM-immune-gut axis in inflammatory bowel disease pathogenesis and therapeutics.

Seminars in immunology·2026
Same journal

Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity.

Seminars in immunology·2026
Same journal

The immune system in Latin America and the Caribbean: Insights into diseases and diversity from local perspectives.

Seminars in immunology·2026
Same journal

Introduction to the special issue: T<sub>H</sub>9 cells in diseases.

Seminars in immunology·2026
See all related articles

Mutations in Bruton's tyrosine kinase (Btk) cause B cell immunodeficiencies. Btk is crucial for B cell survival, proliferation, and response to antigen receptor signaling, impacting calcium flux and gene expression.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Bruton's tyrosine kinase (Btk) is essential for B cell development and function.
  • Mutations in Btk lead to X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice.
  • Btk plays a key role in integrating signals from the B cell antigen receptor (BCR).

Purpose of the Study:

  • To elucidate the critical role of Btk in B cell signaling and homeostasis.
  • To understand how Btk regulates B cell responses to BCR crosslinking.
  • To identify downstream pathways affected by Btk activity.

Main Methods:

  • The study likely involved analyzing Btk-deficient models (XLA/Xid) and wild-type controls.
  • Investigated B cell numbers and function in peripheral lymphoid organs.

Related Experiment Videos

  • Examined BCR signaling pathways, including calcium flux and kinase activation (JNK, p38).

    • Main Results:

    • Btk is indispensable for maintaining peripheral B cell populations.
    • Btk signaling is required for effective B cell responses upon BCR crosslinking.
    • Btk regulates intracellular calcium flux, JNK/p38 activation, and cell cycle gene expression.

    Conclusions:

    • Btk is a central regulator of B cell homeostasis and activation.
    • Dysfunctional Btk impairs critical B cell signaling cascades, leading to immunodeficiency.
    • Targeting Btk pathways may offer therapeutic strategies for B cell disorders.